Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Edginton

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|June 5, 2024
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric populationElizabeth J Thompson, Angela Jeong, Victória E Helfer, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 15, 2019
Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patientsPierre Chelle, Cindy H T Yeung, Santiago Bonanad, et al.
Clinical Pharmacology and Therapeutics|July 22, 2020
Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in InfantsSara N Salerno, Andrea Edginton, Jacqueline G Gerhart, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 23, 2019
Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patientsPierre Chelle, Cindy H T Yeung, Santiago Bonanad, et al.
Journal of Clinical Pharmacology|September 29, 2025
Physiologically Based Pharmacokinetic Modeling of Oxcarbazepine to Characterize Its Disposition in Children with ObesityPatricia D Maglalang, Jaydeep Sinha, Victόria Etges Helfer, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 24, 2025
An Open-Source Framework for Virtual Bioequivalence Modeling and Clinical Trial DesignAbdullah Hamadeh, Moriah Pellowe, Pierre Chelle, et al.
Pharmaceutics|June 28, 2023
Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide AntibioticsKeyur R Parmar, Pradeep B Lukka, Santosh Wagh, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 25, 2026
Midazolam Dosing During CRRT: A Combined Ex Vivo and Physiologically-Based Pharmacokinetic ApproachAutumn M McKnite, Abdullah Hamadeh, J Porter Hunt, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 9, 2024
Integrated Electrochemical Aptamer Biosensing and Colorimetric pH Monitoring via Hydrogel Microneedle Assays for Assessing Antibiotic TreatmentFatemeh Keyvani, Peyman GhavamiNejad, Mahmoud Ayman Saleh, et al.
Clinical Pharmacokinetics|May 30, 2024
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric PopulationPatricia D Maglalang, Jaydeep Sinha, Kanecia Zimmerman, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
CPT: Pharmacometrics & Systems Pharmacology|June 5, 2024
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric populationElizabeth J Thompson, Angela Jeong, Victória E Helfer, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 15, 2019
Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patientsPierre Chelle, Cindy H T Yeung, Santiago Bonanad, et al.
Clinical Pharmacology and Therapeutics|July 22, 2020
Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in InfantsSara N Salerno, Andrea Edginton, Jacqueline G Gerhart, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 23, 2019
Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patientsPierre Chelle, Cindy H T Yeung, Santiago Bonanad, et al.
Journal of Clinical Pharmacology|September 29, 2025
Physiologically Based Pharmacokinetic Modeling of Oxcarbazepine to Characterize Its Disposition in Children with ObesityPatricia D Maglalang, Jaydeep Sinha, Victόria Etges Helfer, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 24, 2025
An Open-Source Framework for Virtual Bioequivalence Modeling and Clinical Trial DesignAbdullah Hamadeh, Moriah Pellowe, Pierre Chelle, et al.
Pharmaceutics|June 28, 2023
Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide AntibioticsKeyur R Parmar, Pradeep B Lukka, Santosh Wagh, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 25, 2026
Midazolam Dosing During CRRT: A Combined Ex Vivo and Physiologically-Based Pharmacokinetic ApproachAutumn M McKnite, Abdullah Hamadeh, J Porter Hunt, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 9, 2024
Integrated Electrochemical Aptamer Biosensing and Colorimetric pH Monitoring via Hydrogel Microneedle Assays for Assessing Antibiotic TreatmentFatemeh Keyvani, Peyman GhavamiNejad, Mahmoud Ayman Saleh, et al.
Clinical Pharmacokinetics|May 30, 2024
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric PopulationPatricia D Maglalang, Jaydeep Sinha, Kanecia Zimmerman, et al.
Pageof 5